Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Study Explores Industry Growth Toward $2.78 Billion

The endoscopic retrograde cholangiopancreatography (ERCP) market is set to experience significant growth in the coming years, driven by advancements in medical technology and rising demand for minimally invasive procedures. This expanding industry is becoming increasingly vital for diagnosing and treating pancreatic and biliary conditions, highlighting its growing importance in healthcare.

Expected Market Growth and Size of the ERCP Market
The ERCP market is projected to reach a valuation of $2.79 billion by 2030, expanding at a compound annual growth rate (CAGR) of 8.3%. This robust growth over the forecast period is largely fueled by improvements in endoscopic training, earlier diagnosis of pancreatic diseases, increased use of therapeutic procedures, upgrades to hospital infrastructure, and a rising trend toward minimally invasive care. Other key market drivers include a higher prevalence of biliary disorders and the widespread adoption of therapeutic endoscopy.

The endoscopic retrograde cholangiopancreatography (ercp) market size has grown strongly in recent years. It will grow from $1.86 billion in 2025 to $2.03 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to gallstone prevalence, aging population, gastrointestinal disease burden, hospital endoscopy expansion, imaging-guided procedures.

Download a free sample of the endoscopic retrograde cholangiopancreatography (ercp) market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20770&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Factors Leading to Increased Demand in the ERCP Sector
One major contributor to market expansion is the rising incidence of biliary diseases, which necessitates more frequent use of ERCP procedures for effective diagnosis and treatment. Additionally, there is a growing preference for minimally invasive gastrointestinal (GI) interventions as they offer reduced recovery times and lower complication risks compared to traditional surgical methods.

The integration of advanced endoscopy units and a focus on early detection of pancreatic conditions also play an essential role in driving the ERCP market forward. These developments improve patient outcomes and broaden the scope of therapeutic applications within the field.

View the full endoscopic retrograde cholangiopancreatography (ercp) market report:
https://www.thebusinessresearchcompany.com/report/endoscopic-retrograde-cholangiopancreatography-ercp-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Key Players Influencing the ERCP Market Landscape
The ERCP market is shaped by several prominent companies, including Medtronic plc, Fujifilm Holdings Corporation, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Ottomed Endoscopy, W. L. Gore & Associates Inc., Streis plc, Cook Group, KARL STORZ SE & Co. KG, CONMED Corporation, PENTAX Medical Inc., AMBU Inc., Samsung Medison Co. Ltd., Medi-Globe GmbH, Telemed System Inc., Micro-Tech Endoscopy Inc., Hobbs Medical Inc., and Shaili Endoscopy Pvt. Ltd.

Medtronic's Strategic Partnership to Enhance ERCP Procedures
In April 2025, Medtronic Plc, a US-based medical technology leader specializing in devices used for ERCP, formed a collaboration with Dragonfly Endoscopy Inc. This alliance aims to distribute the Dragonfly Pancreaticobiliary System across the United States. By combining Medtronic's strong commercialization capabilities and clinical support with Dragonfly Endoscopy's cutting-edge pancreaticobiliary imaging and intervention technology, the partnership seeks to improve precision, visualization, and safety during ERCP procedures. Ultimately, this collaboration is designed to offer gastroenterologists and surgeons a comprehensive solution that enhances procedural effectiveness and patient care.

Innovative Trends Shaping the ERCP Market
Companies in the ERCP sector are concentrating efforts on developing advanced technologies such as cholangioscope direct visualization systems, which provide high-resolution imaging of the bile and pancreatic ducts during procedures. This technology enables more accurate diagnosis and targeted therapeutic interventions.

For example, in July 2024, UK-based Penlon Limited introduced the VedVision Cholangioscope Direct Visualization System. This device offers superior imaging capabilities, featuring a 2 mm accessory channel and a dedicated guidewire channel to ensure secure access. It is further supported by a suite of complementary accessories, including biopsy forceps, stone extraction baskets, cytology brushes, and polypectomy snares, designed to enhance the efficiency and safety of ERCP procedures.

Breakdown of Key ERCP Market Segments
The ERCP market is categorized into several core segments to provide a detailed outlook:

1) By Product Type:
- Endoscopes
- Endotherapy Devices
- Visualization Systems
- Energy Devices

2) By Application:
- Biliary Sphincterotomy
- Biliary Dilatation
- Biliary Stenting
- Pancreatic Sphincterotomy
- Pancreatic Duct Dilatation
- Pancreatic Duct Stenting

3) By End User:
- Hospitals and Clinics
- Ambulatory Surgery Centers
- Other End Users

Further segmentation includes:
- Endoscopes: Flexible, Semi-Rigid, High-Resolution
- Endotherapy Devices: Stone Extraction Tools, Balloon Dilatation Catheters, Stents, Biopsy Forceps
- Visualization Systems: High-Definition Systems, Endoscopic Imaging, Video Endoscopes
- Energy Devices: Electrosurgical, Laser, and Argon Plasma Coagulation Systems

This comprehensive classification highlights the diverse range of products, procedures, and users that define the ERCP market, illustrating its complexity and scope for innovation.

Our 2026 market reports now include enhanced strategic insights through:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.